Literature DB >> 16935856

Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va.

Eva A Norstrøm1, Sinh Tran, Mårten Steen, Björn Dahlbäck.   

Abstract

Activated protein C inhibits the procoagulant function of activated factor V (FVa) through proteolytic cleavages at Arg-306, Arg-506, and Arg-679. The cleavage at Arg-506 is kinetically favored but protected by factor Xa (FXa). Protein S has been suggested to annihilate the inhibitory effect of FXa, a proposal that has been challenged. To elucidate the effects of FXa and protein S on the individual cleavage sites of FVa, we used recombinant FVa:Q306/Q679 and FVa:Q506/Q679 variants, which can only be cleaved at Arg-506 and Arg-306, respectively. In the presence of active site blocked FXa (FXa-1.5-dansyl-Glu-Gly-Arg), the FVa inactivation was followed over time, and apparent second order rate constants were calculated. Consistent with results on record, we observed that FXa-1.5-dansyl-Glu-Gly-Arg decreased the Arg-506 cleavage by 20-fold, with a half-maximum inhibition of approximately 2 nM. Interestingly and in contrast to the inhibitory effect of FXa on the 506 cleavage, FXa stimulated the Arg-306 cleavage. Protein S counteracted the inhibition by FXa of the Arg-506 cleavage, whereas protein S and FXa yielded additive stimulatory effect of the cleavage at Arg-306. This suggests that FXa and protein S interact with distinct sites on FVa, which is consistent with the observed lack of inhibitory effect on FXa binding to FVa by protein S. We propose that the apparent annihilation of the FXa protection of the Arg-506 cleavage by protein S is due to an enhanced rate of Arg-506 cleavage of FVa not bound to FXa, resulting in depletion of free FVa and dissociation of FXa-FVa complexes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935856     DOI: 10.1074/jbc.M606441200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.

Authors:  Thomas J Cramer; John H Griffin; Andrew J Gale
Journal:  Pathophysiol Haemost Thromb       Date:  2010-05-22

2.  Inhibition of thrombin formation by active site mutated (S360A) activated protein C.

Authors:  Gerry A F Nicolaes; Paul E Bock; Kenneth Segers; Karin C A A Wildhagen; Björn Dahlbäck; Jan Rosing
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

3.  Down regulation of prothrombinase by activated protein C during prothrombin activation.

Authors:  Paul Y Kim; Michael E Nesheim
Journal:  Thromb Haemost       Date:  2010-04-13       Impact factor: 5.249

4.  Function of the activated protein C (APC) autolysis loop in activated FVIII inactivation.

Authors:  Thomas J Cramer; Andrew J Gale
Journal:  Br J Haematol       Date:  2011-04-04       Impact factor: 6.998

5.  Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.

Authors:  Xin Huang; Richard Swanson; Heather K Kroh; Paul E Bock
Journal:  J Biol Chem       Date:  2019-03-27       Impact factor: 5.157

6.  Down-regulation of the clotting cascade by the protein C pathway.

Authors:  Fabian Stavenuiter; Eveline A M Bouwens; Laurent O Mosnier
Journal:  Hematol Educ       Date:  2013

7.  Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis.

Authors:  Mårten Steen; Sinh Tran; Ludovic Autin; Bruno O Villoutreix; Ann-Louise Tholander; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

8.  Modeling of human factor Va inactivation by activated protein C.

Authors:  Maria Cristina Bravo; Thomas Orfeo; Kenneth G Mann; Stephen J Everse
Journal:  BMC Syst Biol       Date:  2012-05-20

9.  Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.

Authors:  Ruzica Livaja Koshiar; Sofia Somajo; Eva Norström; Björn Dahlbäck
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

10.  Using Bioinformatics Approach to Explore the Pharmacological Mechanisms of Multiple Ingredients in Shuang-Huang-Lian.

Authors:  Bai-xia Zhang; Jian Li; Hao Gu; Qiang Li; Qi Zhang; Tian-jiao Zhang; Yun Wang; Cheng-ke Cai
Journal:  ScientificWorldJournal       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.